Functional Brands Inc.: Termination of a Material Definitive Agreement

(NASDAQ:MEHA) MEHA filed an Item 1.02: Termination of a Material Definitive Agreement.

Functional Brands Inc. Receives Nasdaq Staff Delisting Determination

(NASDAQ: MEHA) Functional Brands Inc. announced that on June 9, 2026, it received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that Nasdaq has determined to delist the Company's common stock from The Nasdaq Capital Market. On December 30, 2025, the Company received notice from Nasdaq that the closing bid price of its common stock had been below $1.00 per share for 30 consecutive business days, failing to comply with Nasdaq Listing Rule 5550(a)(2). The Company was given 180 calendar days, or until June 29, 2026, to regain compliance with the Bid Price Requirement. As of June 8, 2026, the Company's common stock had a closing bid price of $0.10 or less for ten consecutive trading days, triggering the Staff Determination under Nasdaq Listing Rule 5810(c)(3)(A)(iii). Trading of the Company's common stock will be suspended at the opening of business on June 16, 2026, and a Form 25-NSE will be filed with the SEC to remove the Company's securities from listing and registration on The Nasdaq Stock Market. The Company may request a hearing before the Nasdaq Hearings Panel by submitting a non-refundable fee of $20,000 no later than 4:00 p.m. Eastern Time on June 16, 2026. The company states there can be no assurance that it will be successful in its appeal or that it will be able to regain compliance with Nasdaq's listing requirements within the timeframe that may be provided by the Panel, or at all.

Functional Brands Announces First Quarter 2026 Financial Results

Functional Brands Inc. (NASDAQ: MEHA) announced its financial results for the first quarter ended March 31, 2026. The company reported revenue of $1,645,524, an increase of approximately 3.5% from the prior year period, and gross profit of $961,133, up 11%. Gross margin improved by 390 basis points to 58.4%. However, the company posted an operating loss of $682,805 and a net loss of $6,990,789, which included a $6,310,464 non-cash GAAP charge on equity exchange. Strategic highlights included expansion of Kirkman® distribution, growth in the Tru2u.health platform, and a binding letter of intent for the acquisition of intellectual property and blockchain-based assets. The company also completed a capital structure simplification. These results reflect both operational progress and significant expenses related to becoming a public company, with forward-looking statements cautioning about risks related to the pending acquisition and integration.

Functional Brands Inc. Announces Conversion Price Adjustment Agreement for Series C Preferred Stock

Functional Brands Inc. (NASDAQ: MEHA) announced it has entered into a Conversion Price Reduction and Waiver Agreement with all holders of its Series C Convertible Preferred Stock. The conversion price during the Fixed Conversion Period has been modified to $0.1636 per share of common stock, replacing the existing tiered conversion prices and related tier allocation structure. The company and holders have mutually waived the prohibition on below-price conversions at the reduced conversion price. This move aims to align stockholders, provide preferred holders with a practical path to liquidity, and strengthen the company's financial position. The announcement also includes cautionary statements regarding forward-looking statements and potential acquisition-related risks.

Functional Brands Inc. Signs Binding Letter of Intent for the Acquisition of the Assets of BullionFX | Alchemy for $142.9 million

Functional Brands Inc. (NASDAQ: MEHA) announced it has executed a binding Letter of Intent to acquire the assets of BullionFX, including its core product Alchemy, in an all-stock transaction valued at approximately $142.9 million. The BullionFX Assets include technology, infrastructure, and intellectual property associated with a blockchain-based financial ecosystem designed around auditable physical gold. The acquisition is expected to provide Functional Brands with access to gold-linked digital financial applications and interoperability between traditional financial systems and blockchain-based networks. The transaction is subject to due diligence, regulatory review, board approvals, and other customary closing conditions. The $142.9 million valuation reflects BullionFX's technology infrastructure and early projected revenue from its suite of decentralized financial products.

Functional Brands Inc. Announces Launch of GLP-Squared Injection

Functional Brands Inc. (NASDAQ: MEHA) announced the official launch of GLP-Squared Injection, a dual-peptide injectable combining Semaglutide and Tirzepatide, now exclusively available to members of its digital health platform, Tru2u.health. The product is positioned as a significant advancement in metabolic and weight-management medicine, offering a precision-optimized, clinician-supervised therapy. GLP-Squared Injection is available immediately to qualifying Tru2u.health members following clinician evaluation and approval. The company highlights the growing global GLP-1 therapy market and its strategic positioning to capture market share through its proprietary platform. This launch marks a pivotal expansion of Tru2u.health's therapeutic offerings.

Tru2u.health Expands Digital Health Platform with the Addition of NAD+ - The Cellular Energy Molecule Transforming Modern Wellness

Functional Brands Inc. (NASDAQ: MEHA) announced the expansion of its digital health platform, www.Tru2u.health, with the addition of NAD+ (Nicotinamide Adenine Dinucleotide) therapy. This new offering enhances the platform's suite of wellness solutions, which already includes peptide protocols, GLP-1-based weight management, and board-certified telehealth support. The company highlights the scientific importance of NAD+ in cellular energy, DNA repair, and metabolic health, and positions the therapy as a key tool for optimizing health at the cellular level. The launch is supported by influencer-led marketing and aims to provide individualized, clinically supervised treatment plans. Tru2u.health is now live and onboarding patients nationwide for NAD+ therapy and all platform services.

Functional Brands Inc. Enters Strategic Partnership with partnrup.ai to Accelerate Growth of Tru2u.health

Functional Brands Inc. announced a strategic technology partnership with partnrup.ai. The partnership will deploy partnrup.ai's full technology stack on behalf of Tru2u.health. Functional Brands Inc. is described as a leading innovator in wellness and performance products. The announcement was made on April 22, 2026. This partnership is intended to support and improve partner-driven customer acquisition.